Graeme Henderson - Publications

University of Bristol, Bristol, England, United Kingdom 
Opioid receptor regulation

83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Groom S, Blum NK, Conibear AE, Disney A, Hill R, Husbands SM, Li Y, Toll L, Kliewer A, Schulz S, Henderson G, Kelly E, Bailey CP. A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitization through G protein-coupled receptor kinase. British Journal of Pharmacology. PMID 33245558 DOI: 10.1111/bph.15334  0.362
2020 Gillis A, Kliewer A, Kelly E, Henderson G, Christie MJ, Schulz S, Canals M. Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor. Trends in Pharmacological Sciences. PMID 33097283 DOI: 10.1016/  0.589
2020 Kliewer A, Gillis A, Hill R, Schmidel F, Bailey C, Kelly E, Henderson G, Christie MJ, Schulz S. Morphine-induced respiratory depression is independent of ß-arrestin2 signalling. British Journal of Pharmacology. PMID 32052419 DOI: 10.1111/Bph.15004  0.599
2019 Hill R, Roberts J, Maclachlan J, Dewey W, Kelly E, Henderson G. Prolonged ethanol administration prevents the development of tolerance to morphine-induced respiratory depression. Drug and Alcohol Dependence. 205: 107674. PMID 31715438 DOI: 10.1016/j.drugalcdep.2019.107674  0.415
2019 Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, Bruneau J, Altice FL, Henderson G, Rahimi-Movaghar A, Larney S. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet (London, England). 394: 1560-1579. PMID 31657732 DOI: 10.1016/S0140-6736(19)32229-9  0.402
2019 Conibear AE, Asghar J, Hill R, Henderson G, Borbely E, Tekus V, Helyes Z, Palandri J, Bailey CP, Starke I, von Mentzer B, Kendall D, Kelly E. A novel G protein-biased agonist at the δ opioid receptor with analgesic efficacy in models of chronic pain. The Journal of Pharmacology and Experimental Therapeutics. PMID 31594792 DOI: 10.1124/Jpet.119.258640  0.476
2019 Hill R, Santhakumar R, Dewey W, Kelly E, Henderson G. Fentanyl depression of respiration: comparison with heroin and morphine. British Journal of Pharmacology. PMID 31499594 DOI: 10.1111/Bph.14860  0.679
2018 Kelly E, Henderson G, Bailey CP. Emerging areas of opioid pharmacology. British Journal of Pharmacology. 175: 2715-2716. PMID 29939423 DOI: 10.1111/bph.14343  0.356
2018 Hill R, Disney A, Conibear A, Sutcliffe K, Dewey W, Husbands S, Bailey C, Kelly E, Henderson G. The novel μ-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception. British Journal of Pharmacology. PMID 29582414 DOI: 10.1111/bph.14224  0.508
2018 Hill R, Dewey WL, Kelly E, Henderson G. Oxycodone-induced Tolerance to Respiratory Depression: Reversal by Ethanol, Pregabalin, and Protein Kinase C Inhibition. British Journal of Pharmacology. PMID 29574756 DOI: 10.1111/bph.14219  0.419
2018 Jacob JC, Sakakibara K, Mischel RA, Henderson G, Dewey WL, Akbarali HI. Ethanol Reversal of Oxycodone Tolerance in Dorsal Root Ganglia Neurons. Molecular Pharmacology. PMID 29467238 DOI: 10.1124/Mol.117.110775  0.354
2017 Gonek M, Akbarali HI, Henderson G, Dewey WL. Reversal of Oxycodone and Hydrocodone Tolerance by Diazepam. Brain Research. PMID 28830768 DOI: 10.1016/J.Brainres.2017.08.017  0.469
2017 Sutcliffe KJ, Henderson G, Kelly E, Sessions RB. Drug binding poses relate structure with efficacy in the μ opioid receptor. Journal of Molecular Biology. PMID 28502792 DOI: 10.1016/j.jmb.2017.05.009  0.401
2017 Jacob JC, Poklis JL, Akbarali HI, Henderson G, Dewey WL. Ethanol Reversal of Tolerance to the Antinociceptive Effects of Oxycodone and Hydrocodone. The Journal of Pharmacology and Experimental Therapeutics. PMID 28442580 DOI: 10.1124/Jpet.117.241083  0.33
2017 Withey SL, Hill R, Lyndon A, Dewey WL, Kelly E, Henderson G. Effect of tamoxifen and brain penetrant PKC and JNK inhibitors on tolerance to opioid-induced respiratory depression in mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 28130265 DOI: 10.1124/Jpet.116.238329  0.491
2015 van Amsterdam J, Phillips L, Henderson G, Bell J, Bowden-Jones O, Hammersley R, Ramsey J, Taylor P, Dale-Perera A, Melichar J, van den Brink W, Nutt D. Ranking the harm of non-medically used prescription opioids in the UK. Regulatory Toxicology and Pharmacology : Rtp. PMID 26382614 DOI: 10.1016/J.Yrtph.2015.09.014  0.411
2015 Hill R, Lyndon A, Withey S, Roberts J, Kershaw Y, MacLachlan J, Lingford-Hughes A, Kelly E, Bailey C, Hickman M, Henderson G. Ethanol Reversal of Tolerance to the Respiratory Depressant Effects of Morphine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26171718 DOI: 10.1038/Npp.2015.201  0.463
2015 Lowe JD, Sanderson HS, Cooke AE, Ostovar M, Tsisanova E, Withey SL, Chavkin C, Husbands SM, Kelly E, Henderson G, Bailey CP. Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization. Molecular Pharmacology. 88: 347-56. PMID 26013542 DOI: 10.1124/Mol.115.098293  0.64
2015 Henderson G, Bullmore ET. Reply to Wang and Sadée. Psychopharmacology. 232: 1495-6. PMID 25757674 DOI: 10.1007/s00213-015-3900-7  0.387
2015 Kelly E, Mundell SJ, Sava A, Roth AL, Felici A, Maltby K, Nathan PJ, Bullmore ET, Henderson G. The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours. Psychopharmacology. 232: 305-14. PMID 24973897 DOI: 10.1007/s00213-014-3666-3  0.469
2015 Cooke AE, Oldfield S, Krasel C, Mundell SJ, Henderson G, Kelly E. Morphine-induced internalization of the L83I mutant of the rat μ-opioid receptor. British Journal of Pharmacology. 172: 593-605. PMID 24697554 DOI: 10.1111/bph.12709  0.478
2015 Henderson G. The μ-opioid receptor: an electrophysiologist's perspective from the sharp end. British Journal of Pharmacology. 172: 260-7. PMID 24640948 DOI: 10.1111/bph.12633  0.502
2013 Llorente J, Withey S, Rivero G, Cunningham M, Cooke A, Saxena K, McPherson J, Oldfield S, Dewey WL, Bailey CP, Kelly E, Henderson G. Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons. Molecular Pharmacology. 84: 252-60. PMID 23716621 DOI: 10.1124/Mol.113.085936  0.401
2013 Hull LC, Gabra BH, Bailey CP, Henderson G, Dewey WL. Reversal of morphine analgesic tolerance by ethanol in the mouse. The Journal of Pharmacology and Experimental Therapeutics. 345: 512-9. PMID 23528610 DOI: 10.1124/jpet.112.202184  0.452
2013 Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ. Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacological Reviews. 65: 223-54. PMID 23321159 DOI: 10.1124/Pr.112.005942  0.707
2013 Chen YJ, Oldfield S, Butcher AJ, Tobin AB, Saxena K, Gurevich VV, Benovic JL, Henderson G, Kelly E. Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor. Journal of Neurochemistry. 124: 189-99. PMID 23106126 DOI: 10.1111/Jnc.12071  0.364
2012 Llorente J, Lowe JD, Sanderson HS, Tsisanova E, Kelly E, Henderson G, Bailey CP. μ-Opioid receptor desensitization: homologous or heterologous? The European Journal of Neuroscience. 36: 3636-42. PMID 23002724 DOI: 10.1111/ejn.12003  0.425
2012 Ferreira F, Foley M, Cooke A, Cunningham M, Smith G, Woolley R, Henderson G, Kelly E, Mundell S, Smythe E. Endocytosis of G protein-coupled receptors is regulated by clathrin light chain phosphorylation. Current Biology : Cb. 22: 1361-70. PMID 22704991 DOI: 10.1016/j.cub.2012.05.034  0.309
2012 Llorente J, Santamarta MT, Henderson G, Pineda J. Enhancement of μ-opioid receptor desensitization by nitric oxide in rat locus coeruleus neurons: involvement of reactive oxygen species. The Journal of Pharmacology and Experimental Therapeutics. 342: 552-60. PMID 22593094 DOI: 10.1124/jpet.112.194225  0.454
2012 Rivero G, Llorente J, McPherson J, Cooke A, Mundell SJ, McArdle CA, Rosethorne EM, Charlton SJ, Krasel C, Bailey CP, Henderson G, Kelly E. Endomorphin-2: a biased agonist at the μ-opioid receptor. Molecular Pharmacology. 82: 178-88. PMID 22553358 DOI: 10.1124/mol.112.078659  0.46
2010 McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S, Krasel C, Dewey WL, Bailey CP, Rosethorne EM, Charlton SJ, Henderson G, Kelly E. μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Molecular Pharmacology. 78: 756-66. PMID 20647394 DOI: 10.1124/mol.110.066613  0.455
2010 Hull LC, Llorente J, Gabra BH, Smith FL, Kelly E, Bailey C, Henderson G, Dewey WL. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy. The Journal of Pharmacology and Experimental Therapeutics. 332: 1127-35. PMID 20008489 DOI: 10.1124/jpet.109.161455  0.505
2009 Bailey CP, Oldfield S, Llorente J, Caunt CJ, Teschemacher AG, Roberts L, McArdle CA, Smith FL, Dewey WL, Kelly E, Henderson G. Involvement of PKC alpha and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of mu-opioid receptors in mature brain neurons. British Journal of Pharmacology. 158: 157-64. PMID 19309357 DOI: 10.1111/j.1476-5381.2009.00140.x  0.481
2009 Bailey CP, Llorente J, Gabra BH, Smith FL, Dewey WL, Kelly E, Henderson G. Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. The European Journal of Neuroscience. 29: 307-18. PMID 19200236 DOI: 10.1111/j.1460-9568.2008.06573.x  0.502
2008 Gabra BH, Bailey CP, Kelly E, Smith FL, Henderson G, Dewey WL. Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice. Brain Research. 1217: 70-7. PMID 18501877 DOI: 10.1016/j.brainres.2008.04.036  0.41
2008 Rodriguez-Martin I, Braksator E, Bailey CP, Goodchild S, Marrion NV, Kelly E, Henderson G. Methadone: does it really have low efficacy at micro-opioid receptors? Neuroreport. 19: 589-93. PMID 18388744 DOI: 10.1097/WNR.0b013e3282f97b64  0.42
2008 Kelly E, Bailey CP, Henderson G. Agonist-selective mechanisms of GPCR desensitization. British Journal of Pharmacology. 153: S379-88. PMID 18059321 DOI: 10.1038/sj.bjp.0707604  0.401
2008 Oldfield S, Braksator E, Rodriguez-Martin I, Bailey CP, Donaldson LF, Henderson G, Kelly E. C-terminal splice variants of the mu-opioid receptor: existence, distribution and functional characteristics. Journal of Neurochemistry. 104: 937-45. PMID 18005002 DOI: 10.1111/J.1471-4159.2007.05057.X  0.46
2007 Gabra BH, Bailey CP, Kelly E, Sanders AV, Henderson G, Smith FL, Dewey WL. Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance. Brain Research. 1159: 86-93. PMID 17582387 DOI: 10.1016/j.brainres.2007.05.017  0.415
2006 Bailey CP, Smith FL, Kelly E, Dewey WL, Henderson G. How important is protein kinase C in mu-opioid receptor desensitization and morphine tolerance? Trends in Pharmacological Sciences. 27: 558-65. PMID 17000011 DOI: 10.1016/  0.501
2006 Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, Henderson G. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Molecular Pharmacology. 70: 676-85. PMID 16682505 DOI: 10.1124/mol.106.022376  0.518
2006 Corbett AD, Henderson G, McKnight AT, Paterson SJ. 75 years of opioid research: the exciting but vain quest for the Holy Grail. British Journal of Pharmacology. 147: S153-62. PMID 16402099 DOI: 10.1038/sj.bjp.0706435  0.478
2006 Samways DS, Henderson G. Opioid elevation of intracellular free calcium: possible mechanisms and physiological relevance. Cellular Signalling. 18: 151-61. PMID 16199136 DOI: 10.1016/j.cellsig.2005.08.005  0.45
2004 Bailey CP, Kelly E, Henderson G. Protein kinase C activation enhances morphine-induced rapid desensitization of mu-opioid receptors in mature rat locus ceruleus neurons. Molecular Pharmacology. 66: 1592-8. PMID 15361548 DOI: 10.1124/mol.104.004747  0.514
2003 Bailey CP, Couch D, Johnson E, Griffiths K, Kelly E, Henderson G. Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10515-20. PMID 14627635 DOI: 10.1523/Jneurosci.23-33-10515.2003  0.518
2003 Samways DS, Li WH, Conway SJ, Holmes AB, Bootman MD, Henderson G. Co-incident signalling between mu-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization. The Biochemical Journal. 375: 713-20. PMID 12880387 DOI: 10.1042/Bj20030508  0.403
2001 Yeo A, Samways DSK, Fowler CE, Gunn-Moore F, Henderson G. Coincident signalling between the Gi/Go-coupled δ-opioid receptor and the Gq-coupled m3 muscarinic receptor at the level of intracellular free calcium in SH-SY5Y cells Journal of Neurochemistry. 76: 1688-1700. PMID 11259487 DOI: 10.1046/j.1471-4159.2001.00185.x  0.457
2000 Patel MK, Khakh BS, Henderson G. Properties of native P2X receptors in rat trigeminal mesencephalic nucleus neurones: Lack of correlation with known, heterologously expressed P2X receptors Neuropharmacology. 40: 96-105. PMID 11077075 DOI: 10.1016/S0028-3908(00)00108-8  0.374
1998 Beaumont V, Hepworth MB, Luty JS, Kelly E, Henderson G. Somatostatin receptor desensitization in NG108-15 cells. A consequence of receptor sequestration. The Journal of Biological Chemistry. 273: 33174-83. PMID 9837885 DOI: 10.1074/jbc.273.50.33174  0.419
1998 Jhamandas KH, Sutak M, Henderson G. Antinociceptive and morphine modulatory actions of spinal orphanin FQ Canadian Journal of Physiology and Pharmacology. 76: 314-324. PMID 9673795 DOI: 10.1139/cjpp-76-3-314  0.323
1998 Khakh BS, Henderson G. Hyperpolarization-activated cationic currents (I(h)) in neurones of the trigeminal mesencephalic nucleus of the rat Journal of Physiology. 510: 695-704. PMID 9660886 DOI: 10.1111/J.1469-7793.1998.00695.X  0.308
1998 Grudt TJ, Henderson G. Glycine and GABAA receptor-mediated synaptic transmission in rat substantia gelatinosa: inhibition by mu-opioid and GABAB agonists The Journal of Physiology. 507: Pt 2/-. PMID 9518706 DOI: 10.1111/J.1469-7793.1998.473Bt.X  0.441
1997 Henderson G, McKnight AT. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ Trends in Pharmacological Sciences. 18: 293-300. PMID 9277133 DOI: 10.1016/S0165-6147(97)01093-6  0.472
1997 Connor MA, Keir MJ, Henderson G. delta-opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: lack of evidence for delta-receptor subtypes. Neuropharmacology. 36: 125-33. PMID 9144649 DOI: 10.1016/S0028-3908(96)00144-X  0.586
1997 Connor M, Henderson G. Bradykinin inhibition of N- and L-type calcium channel currents in NG108-15 cells. Neuropharmacology. 36: 115-24. PMID 9144648 DOI: 10.1016/S0028-3908(96)00145-1  0.501
1997 Henderson G, Hughes J, Kosterlitz HW. A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. 1972. British Journal of Pharmacology. 120: 396-8; discussion 39. PMID 9142417 DOI: 10.1111/j.1476-5381.1997.tb06821.x  0.547
1997 Khakh BS, Humphrey PP, Henderson G. ATP-gated cation channels (P2X purinoceptors) in trigeminal mesencephalic nucleus neurons of the rat. The Journal of Physiology. 498: 709-15. PMID 9051582 DOI: 10.1113/Jphysiol.1997.Sp021895  0.322
1997 Connor M, Yeo A, Henderson G. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. British Journal of Pharmacology. 120: 455-63. PMID 9031749 DOI: 10.1038/sj.bjp.0700920  0.515
1996 Watts AE, Williams JT, Henderson G. Baclofen inhibition of the hyperpolarization-activated cation current, Ih, in rat substantia nigra zona compacta neurons may be secondary to potassium current activation. Journal of Neurophysiology. 76: 2262-70. PMID 8899601 DOI: 10.1152/Jn.1996.76.4.2262  0.334
1996 Connor M, Henderson G. delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. British Journal of Pharmacology. 117: 333-40. PMID 8789387 DOI: 10.1111/j.1476-5381.1996.tb15195.x  0.573
1996 Connor M, Yeo A, Henderson G. The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line. British Journal of Pharmacology. 118: 205-7. PMID 8735615 DOI: 10.1111/J.1476-5381.1996.Tb15387.X  0.596
1995 Watts AE, Hicks GA, Henderson G. Putative pre- and postsynaptic ATP-sensitive potassium channels in the rat substantia nigra in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 3065-74. PMID 7722645 DOI: 10.1523/Jneurosci.15-04-03065.1995  0.359
1995 Connor MA, Keir MJ, Henderson G. δ-OPIOJD RECEPTOR MOBILIZATION OF INTRACELLULAR CALCIUM IN SH-SY5Y CELLS: LACK OF EVIDENCE FOR 8 RECEPTOR SUBTYPES Analgesia. 1: 375-378. DOI: 10.3727/107156995819563186  0.473
1994 Hepworth M, Henderson G. Is there a role for protein kinase A in rapid desensitization of δ-opioid and somatostatin responses in NG108-15 cells? Regulatory Peptides. 54: 121-122. DOI: 10.1016/0167-0115(94)90419-7  0.408
1994 Connor M, Planner A, Henderson G. δ and μ opioid receptor mobilization of intracellular calcium in neuroblastoma cells Regulatory Peptides. 54: 65-66. DOI: 10.1016/0167-0115(94)90391-3  0.609
1992 Hicks GA, Henderson G. Lack of evidence for coupling of the dopamine D2 receptor to an adenosine triphosphate-sensitive potassium (ATP-K+) channel in dopaminergic neurones of the rat substantia nigra Neuroscience Letters. 141: 213-217. PMID 1436636 DOI: 10.1016/0304-3940(92)90897-G  0.302
1992 Kennedy C, Henderson G. Chronic exposure to morphine does not induce dependence at the level of the calcium channel current in human SH-SY5Y cells Neuroscience. 49: 937-944. PMID 1279457 DOI: 10.1016/0306-4522(92)90369-D  0.446
1991 Seward E, Hammond C, Henderson G. Mu-opioid-receptor-mediated inhibition of the N-type calcium-channel current. Proceedings. Biological Sciences / the Royal Society. 244: 129-35. PMID 1679547 DOI: 10.1098/Rspb.1991.0061  0.696
1991 Kennedy C, Henderson G. μ-Opioid receptor inhibition of calcium current: Development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro Molecular Pharmacology. 40: 1000-1005. PMID 1661836  0.436
1990 Rogers H, Henderson G. Activation of μ- and δ-opioid receptors present on the same nerve terminals depresses transmitter release in the mouse hypogastric ganglion British Journal of Pharmacology. 101: 505-512. PMID 1981687 DOI: 10.1111/J.1476-5381.1990.Tb14112.X  0.519
1990 Kennedy C, Jarvis GE, Henderson G. The ligand rimcazole antagonises (+)SKF 10,047, but not (+)3-PPP, in the mouse isolated vas deferens European Journal of Pharmacology. 181: 315-318. PMID 1974518 DOI: 10.1016/0014-2999(90)90097-P  0.343
1990 Seward EP, Henderson G. Characterization of two components of the N-like, high-threshold-activated calcium channel current in differentiated SH-SY5Y cells. PflüGers Archiv : European Journal of Physiology. 417: 223-30. PMID 1964725 DOI: 10.1007/BF00370703  0.585
1990 Kennedy C, Seward EP, Henderson G. Induction of tolerance to the inhibitory effect of mu opioid receptor agonists on the calcium current in human neuroblastoma SH-SY5Y cells New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 302.  0.667
1987 McFadzean I, Lacey MG, Hill RG, Henderson G. Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro Neuroscience. 20: 231-239. PMID 3031541 DOI: 10.1016/0306-4522(87)90015-7  0.468
1985 Williams JT, Henderson G, North RA. Characterization of alpha 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones. Neuroscience. 14: 95-101. PMID 2579354 DOI: 10.1016/0306-4522(85)90166-6  0.479
1985 Henderson G, McFadzean I. Opioids - a review of recent developments Chemistry in Britain. 21: 1094-1097.  0.311
1983 Egan TM, Henderson G, North RA, Williams JT. Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones. The Journal of Physiology. 345: 477-88. PMID 6141289 DOI: 10.1113/jphysiol.1983.sp014990  0.468
1983 Henderson G. Electrophysiological analysis of opioid action in the central nervous system British Medical Bulletin. 39: 59-64. PMID 6132650 DOI: 10.1093/Oxfordjournals.Bmb.A071792  0.454
1978 Henderson G, Hughes J, Kosterlitz HW. In vitro release of Leu- and Met-enkephalin from the corpus striatum. Nature. 271: 677-9. PMID 24181 DOI: 10.1038/271677a0  0.448
1977 Waterfield AA, Smokcum RW, Hughes J, Kosterlitz HW, Henderson G. In vitro pharmacology of the opioid peptides, enkephalins and endorphins. European Journal of Pharmacology. 43: 107-16. PMID 17538 DOI: 10.1016/0014-2999(77)90123-6  0.569
1975 Henderson G, Hughes J, Kosterlitz HW. The effects of morphine on the release of noradrenaline from the cat isolated nictitating membrane and the guinea-pig ileum myenteric plexus-longitudinal muscle preparation. British Journal of Pharmacology. 53: 505-12. PMID 1148493  0.49
1972 Henderson G, Hughes J, Kosterlitz HW. A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. British Journal of Pharmacology. 46: 764-6. PMID 4655272  0.615
Show low-probability matches.